January 13, 2017 (Shareholders Foundation) - An investigation on behalf of investors of Davita Inc (NYSE:DVA) shares over potential securities laws violations by Davita Inc and certain of its directors and officers in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Davita Inc (NYSE:DVA) concerning whether a series of statements by Davita Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On January 6, 2017, after the close of trading, an article was published revealing that Davita Inc allegedly had received subpoenas from federal prosecutors seeking the production of information related to charitable premium assistance in connection with Davita Incs ties to the American Kidney Fund, a charity that helps patients pay for kidney dialysis.

Shares of Davita Inc (NYSE:DVA) declined to $62.88 per share on January 9, 2017.

On January 13, 2017, NYSE:DVA shares closed at $63.93 per share.